Handelsavisen
prelaunch
Companies ›Healthcare ›EUKE.MI
EU
EUKE.MI — Borsa Italiana Healthcare Facilities & Services

Euke.Mi

€0,63
Open in Charts → Attach watcher ⌖
— —
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
10,5 %
ROE
-2,6 %
Net margin
-1,5 %
Debt / equity
4,17
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

EUKE.MI operates in the healthcare sector, focusing on pharmaceuticals and healthcare facilities and services.

Business. EUKE.MI operates in the healthcare sector, focusing on pharmaceuticals and healthcare facilities and services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
-2,6 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning EUKE.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to EUKE.MI. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    EUKE.MI operates in the healthcare sector, focusing on pharmaceuticals and healthcare facilities and services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    EUKE.MI's capital structure is characterized by a high debt-to-equity ratio of 4.17, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.21, suggesting that it may struggle to meet short-term obligations. The company's free cash flow is negative at -798,000 EUR, which could limit its ability to fund operations and growth initiatives.

    In terms of profitability, EUKE.MI's return on equity is -2.57%, and its return on assets is -0.42%, both of which are below the industry median for Healthcare Facilities & Services. The company's net income is negative at -749,000 EUR, indicating a loss for the period. The operating income of 5,403,000 EUR is a positive figure, but it is not sufficient to offset the net loss.

    EUKE.MI's revenue is concentrated in a single segment, as there are no disclosed segments in the financial data. The company's geographic exposure is not specified in the available data, but the revenue concentration suggests that it may be vulnerable to regional economic fluctuations.

    The company's growth trajectory is uncertain, as the outlook for the current fiscal year does not provide specific numeric deltas for revenue growth. The historical revenue data shows a revenue of 51,639,000 EUR, which is slightly below the analyst estimate of 52,907,000 EUR. The lack of detailed growth projections makes it difficult to assess the company's future performance.

    The risk assessment for EUKE.MI indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which is a key flag for liquidity concerns. The dilution risk is low, as there is no indication of significant share issuance or dilution potential.

    Recent events and filings for EUKE.MI do not provide specific details, as the available data does not include recent filings or transcripts. The company's financial performance and risk profile suggest that it may need to address its liquidity and profitability issues to sustain long-term growth.

    Key takeaways
    • EUKE.MI has a high debt-to-equity ratio of 4.17, indicating a significant reliance on debt financing.
    • The company's return on equity is -2.57%, and its return on assets is -0.42%, both of which are below the industry median.
    • EUKE.MI's liquidity position is weak, as evidenced by a current ratio of 0.21.
    • The company's revenue is concentrated in a single segment, which may make it vulnerable to regional economic fluctuations.
    • The company's growth trajectory is uncertain, as the outlook for the current fiscal year does not provide specific numeric deltas for revenue growth.
    • margin_outlook_rationale: The company's margin outlook is uncertain due to the lack of detailed growth projections and the current net loss.
    • rd_outlook_rationale: The company's R&D outlook is not specified in the available data.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    €0,63
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    €29.1M
    Net cashⓘ
    -€121.5M
    Current ratioⓘ
    0.2
    Debt / equityⓘ
    4.2
    ROAⓘ
    -0.4%
    ROEⓘ
    -2.6%
    Cash conversionⓘ
    -833.0%
    CapEx / revenueⓘ
    -11.2%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin10,5 %Above median
    Net Margin-1,5 %Below median
    ROE-2,6 %Bottom quartile
    Capex / Rev-11,2 %Below median
    D/E4,17Bottom quartile
    Cash Conv-8,33Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • EUKE.MI Market data — financials · 2026-05-27
    • Eukedos SpA Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Leadership

    • Carlo IuculanoChairman of the Board, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    EUKE.MICanonical
    Borsa Italiana · EUR

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage